APA

Ghaleiha A., Ghyasvand M., Mohammadi M., Farokhnia M., Yadegari N., Tabrizi M., Hajiaghaee R., Yekehtaz H. & Akhondzadeh S. (20180116). Galantamine efficacy and tolerability as an augmentative therapy in autistic children: A randomized, double-blind, placebo-controlled trial. : Journal of psychopharmacology (Oxford, England).

Chicago

Ghaleiha Ali, Ghyasvand Mohammad, Mohammadi Mohammad-Reza, Farokhnia Mehdi, Yadegari Noorollah, Tabrizi Mina, Hajiaghaee Reza, Yekehtaz Habibeh and Akhondzadeh Shahin. 20180116. Galantamine efficacy and tolerability as an augmentative therapy in autistic children: A randomized, double-blind, placebo-controlled trial. : Journal of psychopharmacology (Oxford, England).

Harvard

Ghaleiha A., Ghyasvand M., Mohammadi M., Farokhnia M., Yadegari N., Tabrizi M., Hajiaghaee R., Yekehtaz H. and Akhondzadeh S. (20180116). Galantamine efficacy and tolerability as an augmentative therapy in autistic children: A randomized, double-blind, placebo-controlled trial. : Journal of psychopharmacology (Oxford, England).

MLA

Ghaleiha Ali, Ghyasvand Mohammad, Mohammadi Mohammad-Reza, Farokhnia Mehdi, Yadegari Noorollah, Tabrizi Mina, Hajiaghaee Reza, Yekehtaz Habibeh and Akhondzadeh Shahin. Galantamine efficacy and tolerability as an augmentative therapy in autistic children: A randomized, double-blind, placebo-controlled trial. : Journal of psychopharmacology (Oxford, England). 20180116.